Barclays PLC Dbv Technologies S.A. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024
SELL
$0.7 - $1.33 $186 - $355
-267 Reduced 6.95%
3,573 $3,000
Q3 2023

Nov 07, 2023
BUY
$1.3 - $1.88 $536 - $776
413 Added 12.05%
3,840 $5,000
Q2 2023

Aug 03, 2023
BUY
$1.42 - $2.23 $230 - $361
162 Added 4.96%
3,427 $7,000
Q1 2023

May 04, 2023
BUY
$1.28 - $1.73 $1,603 - $2,167
1,253 Added 62.28%
3,265 $6,000
Q4 2022

Feb 13, 2023
BUY
$1.16 - $1.8 $1,300 - $2,017
1,121 Added 125.81%
2,012 $3,000
Q3 2022

Nov 03, 2022
BUY
$1.77 - $2.76 $1,074 - $1,675
607 Added 213.73%
891 $2,000
Q2 2022

Aug 12, 2022
BUY
$1.15 - $3.25 $326 - $923
284 New
284 $1,000
Q1 2022

May 16, 2022
SELL
$1.22 - $1.77 $90 - $130
-74 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$1.39 - $5.58 $51 - $206
37 Added 100.0%
74 $0
Q3 2021

Nov 09, 2021
BUY
$4.71 - $5.92 $174 - $219
37 New
37 $0
Q1 2020

May 13, 2020
SELL
$2.33 - $12.98 $435 - $2,427
-187 Closed
0 $0
Q4 2019

Feb 10, 2020
SELL
$6.75 - $11.15 $3,098 - $5,117
-459 Reduced 71.05%
187 $2,000
Q3 2019

Nov 14, 2019
SELL
$8.57 - $10.72 $39,987 - $50,019
-4,666 Reduced 87.84%
646 $5,000
Q2 2019

Aug 14, 2019
BUY
$7.58 - $10.0 $38,150 - $50,330
5,033 Added 1803.94%
5,312 $44,000
Q1 2019

May 15, 2019
BUY
$5.81 - $9.37 $1,162 - $1,873
200 Added 253.16%
279 $2,000
Q4 2018

Feb 14, 2019
SELL
$5.75 - $21.85 $20,533 - $78,026
-3,571 Reduced 97.84%
79 $1,000
Q3 2018

Nov 14, 2018
BUY
$16.81 - $24.58 $61,289 - $89,618
3,646 Added 91150.0%
3,650 $82,000
Q2 2018

Aug 14, 2018
SELL
$18.6 - $24.94 $276,358 - $370,558
-14,858 Reduced 99.97%
4 $0
Q1 2018

May 15, 2018
SELL
$20.86 - $26.6 $688,025 - $877,347
-32,983 Reduced 68.94%
14,862 $343,000
Q4 2017

Feb 14, 2018
BUY
$20.9 - $49.36 $999,960 - $2.36 Million
47,845
47,845 $1.18 Million

Others Institutions Holding DBVT

# of Institutions
4
Shares Held
253K
Call Options Held
0
Put Options Held
0
View Full List

About DBV Technologies S.A.

DBVT Quotes by TradingView
  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $128M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email